Does Zynex, Inc. (NASDAQ:ZYXI) Have A Good P/E Ratio?

In this article:

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use Zynex, Inc.'s (NASDAQ:ZYXI) P/E ratio to inform your assessment of the investment opportunity. Zynex has a P/E ratio of 32.75, based on the last twelve months. That is equivalent to an earnings yield of about 3.1%.

View our latest analysis for Zynex

How Do I Calculate A Price To Earnings Ratio?

The formula for P/E is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Zynex:

P/E of 32.75 = $9.85 ÷ $0.30 (Based on the year to June 2019.)

Is A High P/E Ratio Good?

A higher P/E ratio means that investors are paying a higher price for each $1 of company earnings. All else being equal, it's better to pay a low price -- but as Warren Buffett said, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.

How Does Zynex's P/E Ratio Compare To Its Peers?

One good way to get a quick read on what market participants expect of a company is to look at its P/E ratio. The image below shows that Zynex has a lower P/E than the average (42.5) P/E for companies in the medical equipment industry.

NasdaqCM:ZYXI Price Estimation Relative to Market, September 24th 2019
NasdaqCM:ZYXI Price Estimation Relative to Market, September 24th 2019

Its relatively low P/E ratio indicates that Zynex shareholders think it will struggle to do as well as other companies in its industry classification. Since the market seems unimpressed with Zynex, it's quite possible it could surprise on the upside. It is arguably worth checking if insiders are buying shares, because that might imply they believe the stock is undervalued.

How Growth Rates Impact P/E Ratios

P/E ratios primarily reflect market expectations around earnings growth rates. That's because companies that grow earnings per share quickly will rapidly increase the 'E' in the equation. Therefore, even if you pay a high multiple of earnings now, that multiple will become lower in the future. And as that P/E ratio drops, the company will look cheap, unless its share price increases.

Zynex's earnings per share were pretty steady over the last year.

A Limitation: P/E Ratios Ignore Debt and Cash In The Bank

The 'Price' in P/E reflects the market capitalization of the company. In other words, it does not consider any debt or cash that the company may have on the balance sheet. The exact same company would hypothetically deserve a higher P/E ratio if it had a strong balance sheet, than if it had a weak one with lots of debt, because a cashed up company can spend on growth.

Such expenditure might be good or bad, in the long term, but the point here is that the balance sheet is not reflected by this ratio.

How Does Zynex's Debt Impact Its P/E Ratio?

Since Zynex holds net cash of US$10m, it can spend on growth, justifying a higher P/E ratio than otherwise.

The Bottom Line On Zynex's P/E Ratio

Zynex has a P/E of 32.8. That's higher than the average in its market, which is 18.0. The recent drop in earnings per share might keep value investors away, but the net cash position means the company has time to improve: and the high P/E suggests the market thinks it will.

Investors have an opportunity when market expectations about a stock are wrong. If the reality for a company is better than it expects, you can make money by buying and holding for the long term. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

But note: Zynex may not be the best stock to buy. So take a peek at this free list of interesting companies with strong recent earnings growth (and a P/E ratio below 20).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

Advertisement